NASDAQ:CTMX
CytomX Therapeutics Stock News
$4.37
-0.0600 (-1.35%)
At Close: May 06, 2024
New York, New York--(Newsfile Corp. - July 16, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytomX Therapeutics, Inc. (NASDAQ: CTMX) a
NEW YORK, NY / ACCESSWIRE / July 16, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the ...
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and BKD
04:10pm, Thursday, 16'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 16, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. S
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and IDEX
03:30pm, Thursday, 16'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 16, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. S
NEW YORK, NY / ACCESSWIRE / July 16, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the ...
New York, New York--(Newsfile Corp. - July 16, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
Los Angeles, California--(Newsfile Corp. - July 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
CytomX Investors: Last Days to Seek Participation in Class Action as Lead Plaintiff
12:00pm, Thursday, 16'th Jul 2020
LOS ANGELES, July 16, 2020 -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of CytomX Therapeutics, Inc. investors (NASDAQ: CTMX).
CytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Earnings of $0.34 Per Share
11:28pm, Wednesday, 15'th Jul 2020
Wall Street analysts expect CytomX Therapeutics Inc (NASDAQ:CTMX) to announce earnings of $0.34 per share for the current quarter, according to Zacks Investment Research. Four analysts have made estim
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of R, CTMX and JCOM
01:55pm, Wednesday, 15'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 15, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
Los Angeles, California--(Newsfile Corp. - July 15, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
New York, New York--(Newsfile Corp. - July 14, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the Company") (Nasdaq: CTMX) and certain of its officers
New York, New York--(Newsfile Corp. - July 14, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDAQ:
Los Angeles, California--(Newsfile Corp. - July 14, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
